Ampio Pharmaceuticals Inc (AMPE)
0.285
0.00 (0.00%)
USD |
OTCM |
Apr 24, 13:31
Ampio Pharmaceuticals Cash from Financing (TTM): 0.00 for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | -0.111M |
September 30, 2022 | 20.37M |
June 30, 2022 | 20.86M |
March 31, 2022 | 27.94M |
December 31, 2021 | 30.73M |
September 30, 2021 | 21.13M |
June 30, 2021 | 27.91M |
March 31, 2021 | 27.86M |
December 31, 2020 | 25.61M |
September 30, 2020 | 17.97M |
June 30, 2020 | 10.70M |
March 31, 2020 | 14.77M |
December 31, 2019 | 14.35M |
September 30, 2019 | 12.42M |
June 30, 2019 | 19.69M |
March 31, 2019 | 8.998M |
December 31, 2018 | 12.08M |
September 30, 2018 | 19.77M |
June 30, 2018 | 12.52M |
March 31, 2018 | 17.90M |
December 31, 2017 | 14.79M |
Date | Value |
---|---|
September 30, 2017 | 5.847M |
June 30, 2017 | 9.298M |
March 31, 2017 | 3.528M |
December 31, 2016 | 3.528M |
September 30, 2016 | 19.76M |
June 30, 2016 | 21.18M |
March 31, 2016 | 21.16M |
December 31, 2015 | 21.16M |
September 30, 2015 | 10.38M |
June 30, 2015 | 5.469M |
March 31, 2015 | 5.488M |
December 31, 2014 | 68.93M |
September 30, 2014 | 63.71M |
June 30, 2014 | 88.74M |
March 31, 2014 | 89.81M |
December 31, 2013 | 29.43M |
September 30, 2013 | 29.13M |
June 30, 2013 | 19.49M |
March 31, 2013 | 19.04M |
December 31, 2012 | 16.02M |
September 30, 2012 | 24.52M |
June 30, 2012 | 9.349M |
March 31, 2012 | 14.31M |
December 31, 2011 | 19.94M |
September 30, 2011 | 12.84M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.111M
Minimum
Dec 2022
30.73M
Maximum
Dec 2021
15.38M
Average
17.97M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
NeuBase Therapeutics Inc | 4.254M |
Tivic Health Systems Inc | 8.507M |
Oragenics Inc | 0.2839M |
Actinium Pharmaceuticals Inc | 14.87M |
MAIA Biotechnology Inc | 9.271M |